Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Specialized CD4+ T-Cell Subset Protects Residual Leukemic Cells from Immune Surveillance, Enabling Relapse

Sean Tracy, Hrishi Venkatesh, Todd P. Knutson, Yinjie Qiu, Michael A. Farrar

Blood (2023) 142 (Supplement 1): 597.

https://doi.org/10.1182/blood-2023-186951

Published: 2023

Journal Articles

Combining nilotinib and PD-L1 blockade reverses CD4 + T-cell dysfunction and prevents relapse in acute B-cell leukemia

Sean I. Tracy, Hrishi Venkatesh, Can Hekim, Lynn M. Heltemes-Harris, Todd P. Knutson, Veronika Bachanova, Michael A. Farrar

Blood (2022) 140 (4): 335–348.

https://doi.org/10.1182/blood.2021015341

Published: 2022

Includes: Supplemental data

Journal Articles

Constitutively active Stat5b in CD4 + T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses

Christine Vogtenhuber, Christoph Bucher, Steven L. Highfill, Lisa K. Koch, Emily Goren, Angela Panoskaltsis-Mortari, Patricia A. Taylor, Michael A. Farrar, Bruce R. Blazar

Blood (2010) 116 (3): 466–474.

https://doi.org/10.1182/blood-2009-11-252825

Published: 2010

Includes: Supplemental data

Journal Articles

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells

Xueqing Liang, E. Ashley Moseman, Michael A. Farrar, Veronika Bachanova, Daniel J. Weisdorf, Bruce R. Blazar, Wei Chen

Blood (2010) 115 (24): 5041–5052.

https://doi.org/10.1182/blood-2009-03-213363

Published: 2010

Journal Articles

BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3

Joji Nakayama, Mutsumi Yamamoto, Katsuhiko Hayashi, Hitoshi Satoh, Kenji Bundo, Masato Kubo, Ryo Goitsuka, Michael A. Farrar, Daisuke Kitamura

Blood (2009) 113 (7): 1483–1492.

https://doi.org/10.1182/blood-2008-07-166355

Published: 2009

Includes: Supplemental data

Journal Articles

Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection

Robert S. Welner, Rosana Pelayo, Yoshinori Nagai, Karla P. Garrett, Todd R. Wuest, Daniel J. Carr, Lisa A. Borghesi, Michael A. Farrar, Paul W. Kincade

Blood (2008) 112 (9): 3753–3761.

https://doi.org/10.1182/blood-2008-04-151506

Published: 2008

Includes: Supplemental data

NARROW

A Specialized CD4+ T-Cell Subset Protects Residual Leukemic Cells from Immune Surveillance, Enabling Relapse

Combining nilotinib and PD-L1 blockade reverses CD4 + T-cell dysfunction and prevents relapse in acute B-cell leukemia

Constitutively active Stat5b in CD4 + T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells

BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3

Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection

Email alerts

ASH Publications

American Society of Hematology

A Specialized CD4+ T-Cell Subset Protects Residual Leukemic Cells from Immune Surveillance, Enabling Relapse

Combining nilotinib and PD-L1 blockade reverses CD4 + T-cell dysfunction and prevents relapse in acute B-cell leukemia

Constitutively active Stat5b in CD4 + T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells

BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3

Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only